$312 Million is the total value of Nan Fung Group Holdings Ltd's 28 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ILMN | New | ILLUMINA INC | $52,586,000 | – | 129,647 | +100.0% | 16.83% | – |
New | SOMALOGIC INC | $21,020,000 | – | 1,696,558 | +100.0% | 6.73% | – | |
New | RANI THERAPEUTICS HLDGS INC | $8,796,000 | – | 493,584 | +100.0% | 2.82% | – | |
VIR | Buy | VIR BIOTECHNOLOGY INC | $6,972,000 | +114.8% | 160,211 | +133.3% | 2.23% | +121.2% |
BEAM | Buy | BEAM THERAPEUTICS INC | $4,777,000 | -23.7% | 54,903 | +12.8% | 1.53% | -21.4% |
ALXO | Buy | ALX ONCOLOGY HLDGS INC | $3,098,000 | +62.1% | 41,950 | +20.0% | 0.99% | +67.0% |
DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $1,818,000 | +16.6% | 370,950 | +29.9% | 0.58% | +20.2% |
STSA | New | SATSUMA PHARMACEUTICALS INC | $666,000 | – | 142,900 | +100.0% | 0.21% | – |
FLNT | Buy | FLUENT INC | $442,000 | -22.6% | 194,800 | +0.0% | 0.14% | -20.3% |
DYN | New | DYNE THERAPEUTICS INC | $189,000 | – | 11,629 | +100.0% | 0.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
KARUNA THERAPEUTICS INC | 10 | Q3 2023 | 34.7% |
HARMONY BIOSCIENCES HLDGS IN | 10 | Q3 2023 | 21.3% |
XENON PHARMACEUTICALS INC | 10 | Q3 2023 | 3.1% |
BOLT BIOTHERAPEUTICS INC | 10 | Q3 2023 | 5.6% |
GALERA THERAPEUTICS INC | 10 | Q3 2023 | 1.9% |
KALVISTA PHARMACEUTICALS INC | 10 | Q3 2023 | 1.8% |
EXELIXIS INC | 10 | Q3 2023 | 1.1% |
DBV TECHNOLOGIES S A | 10 | Q3 2023 | 0.6% |
ALX ONCOLOGY HLDGS INC | 10 | Q3 2023 | 1.0% |
ILLUMINA INC | 9 | Q3 2023 | 21.5% |
View Nan Fung Group Holdings Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Eargo, Inc. | December 16, 2022 | 2,958,099 | 0.7% |
Stealth BioTherapeutics Corp | January 09, 2020 | 20,240,817 | 4.8% |
New Frontier Health Corp | January 02, 2020 | 9,650,000 | 7.3% |
View Nan Fung Group Holdings Ltd's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
SC 13D/A | 2022-12-16 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
View Nan Fung Group Holdings Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.